speb/financial-data huggingface dataset:
IPCALAB.NS balance_sheet (annual, 2024-03-31) — Share Issued: 253704218.00
IPCALAB.NS income_statement (annual, 2024-03-31) — Special Income Charges: -1081500000.00
IPCALAB.NS cash_flow (annual, 2024-03-31) — Stock Based Compensation: 30600000.00
IPCALAB.NS balance_sheet (annual, 2024-03-31) — Stockholders Equity: 63321900000.00
IPCALAB.NS balance_sheet (annual, 2024-03-31) — Tangible Book Value: 60990100000.00
IPCALAB.NS income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: -198788403.53
IPCALAB.NS income_statement (annual, 2024-03-31) — Tax Provision: 3134600000.00
IPCALAB.NS income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.37
IPCALAB.NS balance_sheet (annual, 2024-03-31) — Taxes Receivable: 1315800000.00
IPCALAB.NS cash_flow (annual, 2024-03-31) — Taxes Refund Paid: -2963000000.00
IPCALAB.NS balance_sheet (annual, 2024-03-31) — Total Assets: 111012800000.00
IPCALAB.NS balance_sheet (annual, 2024-03-31) — Total Capitalization: 69126000000.00
IPCALAB.NS balance_sheet (annual, 2024-03-31) — Total Debt: 14383600000.00
IPCALAB.NS balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 77270000000.00
IPCALAB.NS income_statement (annual, 2024-03-31) — Total Expenses: 66879400000.00
IPCALAB.NS balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 33742800000.00
IPCALAB.NS balance_sheet (annual, 2024-03-31) — Total Non Current Assets: 55623400000.00
IPCALAB.NS balance_sheet (annual, 2024-03-31) — Total Non Current Liabilities Net Minority Interest: 10186400000.00
IPCALAB.NS income_statement (annual, 2024-03-31) — Total Other Finance Cost: 34600000.00
IPCALAB.NS balance_sheet (annual, 2024-03-31) — Total Tax Payable: 882200000.00
IPCALAB.NS income_statement (annual, 2024-03-31) — Total Unusual Items: -534400000.00
IPCALAB.NS income_statement (annual, 2024-03-31) — Total Unusual Items Excluding Goodwill: -534400000.00
IPCALAB.NS balance_sheet (annual, 2024-03-31) — Tradeand Other Payables Non Current: 8700000.00
IPCALAB.NS balance_sheet (annual, 2024-03-31) — Work In Process: 4170000000.00
IPCALAB.NS balance_sheet (annual, 2024-03-31) — Working Capital: 31832600000.00
IPCALAB.NS income_statement (annual, 2024-03-31) — Write Off: 117600000.00
IPCALAB.NS balance_sheet (quarterly, 2024-09-30) — Accounts Payable: 9060800000.00
IPCALAB.NS balance_sheet (quarterly, 2024-09-30) — Accounts Receivable: 18135900000.00
IPCALAB.NS balance_sheet (quarterly, 2024-09-30) — Assets Held For Sale Current: 63300000.00
IPCALAB.NS balance_sheet (quarterly, 2024-09-30) — Available For Sale Securities: 2321300000.00
IPCALAB.NS balance_sheet (quarterly, 2024-09-30) — Capital Lease Obligations: 457300000.00
IPCALAB.NS balance_sheet (quarterly, 2024-09-30) — Capital Stock: 253700000.00
IPCALAB.NS balance_sheet (quarterly, 2024-09-30) — Cash And Cash Equivalents: 2559400000.00
IPCALAB.NS balance_sheet (quarterly, 2024-09-30) — Cash Cash Equivalents And Short Term Investments: 9446300000.00
IPCALAB.NS balance_sheet (quarterly, 2024-09-30) — Common Stock: 253700000.00
IPCALAB.NS balance_sheet (quarterly, 2024-09-30) — Common Stock Equity: 67003900000.00
IPCALAB.NS balance_sheet (quarterly, 2024-09-30) — Construction In Progress: 4852600000.00
IPCALAB.NS balance_sheet (quarterly, 2024-09-30) — Current Assets: 56806900000.00
IPCALAB.NS balance_sheet (quarterly, 2024-09-30) — Current Capital Lease Obligation: 103700000.00
IPCALAB.NS balance_sheet (quarterly, 2024-09-30) — Current Debt: 6993300000.00
IPCALAB.NS balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 7097000000.00
IPCALAB.NS balance_sheet (quarterly, 2024-09-30) — Current Liabilities: 23959000000.00
IPCALAB.NS balance_sheet (quarterly, 2024-09-30) — Current Provisions: 2641000000.00
IPCALAB.NS balance_sheet (quarterly, 2024-09-30) — Goodwill: 905800000.00
IPCALAB.NS balance_sheet (quarterly, 2024-09-30) — Goodwill And Other Intangible Assets: 2311700000.00
IPCALAB.NS balance_sheet (quarterly, 2024-09-30) — Gross PPE: 47764300000.00
IPCALAB.NS balance_sheet (quarterly, 2024-09-30) — Inventory: 25183100000.00
IPCALAB.NS balance_sheet (quarterly, 2024-09-30) — Invested Capital: 78568400000.00
IPCALAB.NS balance_sheet (quarterly, 2024-09-30) — Investmentin Financial Assets: 2321300000.00
IPCALAB.NS balance_sheet (quarterly, 2024-09-30) — Long Term Capital Lease Obligation: 353600000.00
IPCALAB.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt: 4571200000.00
IPCALAB.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 4924800000.00
IPCALAB.NS balance_sheet (quarterly, 2024-09-30) — Long Term Equity Investment: 1937400000.00
IPCALAB.NS balance_sheet (quarterly, 2024-09-30) — Long Term Provisions: 955600000.00
IPCALAB.NS balance_sheet (quarterly, 2024-09-30) — Minority Interest: 14172700000.00
IPCALAB.NS balance_sheet (quarterly, 2024-09-30) — Net Debt: 9005100000.00
IPCALAB.NS balance_sheet (quarterly, 2024-09-30) — Net PPE: 47764300000.00
IPCALAB.NS balance_sheet (quarterly, 2024-09-30) — Net Tangible Assets: 64692200000.00
IPCALAB.NS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Assets: 61800000.00
IPCALAB.NS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Liabilities: 3215300000.00
IPCALAB.NS balance_sheet (quarterly, 2024-09-30) — Ordinary Shares Number: 253704218.00
IPCALAB.NS balance_sheet (quarterly, 2024-09-30) — Other Current Assets: 3562700000.00
IPCALAB.NS balance_sheet (quarterly, 2024-09-30) — Other Current Liabilities: 890200000.00
IPCALAB.NS balance_sheet (quarterly, 2024-09-30) — Other Equity Interest: 66750200000.00
IPCALAB.NS balance_sheet (quarterly, 2024-09-30) — Other Intangible Assets: 1405900000.00
IPCALAB.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Assets: 2642000000.00
IPCALAB.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Liabilities: 6400000.00
IPCALAB.NS balance_sheet (quarterly, 2024-09-30) — Other Properties: 42911700000.00
IPCALAB.NS balance_sheet (quarterly, 2024-09-30) — Other Receivables: 415600000.00
IPCALAB.NS balance_sheet (quarterly, 2024-09-30) — Other Short Term Investments: 6886900000.00
IPCALAB.NS balance_sheet (quarterly, 2024-09-30) — Payables: 9776700000.00
IPCALAB.NS income_statement (quarterly, 2024-09-30) — Restructuring And Mergern Acquisition: 0.00
IPCALAB.NS balance_sheet (quarterly, 2024-09-30) — Share Issued: 253704218.00
IPCALAB.NS balance_sheet (quarterly, 2024-09-30) — Stockholders Equity: 67003900000.00
IPCALAB.NS balance_sheet (quarterly, 2024-09-30) — Tangible Book Value: 64692200000.00
IPCALAB.NS balance_sheet (quarterly, 2024-09-30) — Taxes Receivable: 0.00
IPCALAB.NS balance_sheet (quarterly, 2024-09-30) — Total Assets: 114237700000.00
IPCALAB.NS balance_sheet (quarterly, 2024-09-30) — Total Capitalization: 71575100000.00
IPCALAB.NS balance_sheet (quarterly, 2024-09-30) — Total Debt: 12021800000.00
IPCALAB.NS balance_sheet (quarterly, 2024-09-30) — Total Equity Gross Minority Interest: 81176600000.00
IPCALAB.NS balance_sheet (quarterly, 2024-09-30) — Total Liabilities Net Minority Interest: 33061100000.00
IPCALAB.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Assets: 57430800000.00
IPCALAB.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Liabilities Net Minority Interest: 9102100000.00
IPCALAB.NS balance_sheet (quarterly, 2024-09-30) — Total Tax Payable: 715900000.00
IPCALAB.NS balance_sheet (quarterly, 2024-09-30) — Working Capital: 32847900000.00
IPCALAB.NS income_statement (quarterly, 2024-12-31) — Restructuring And Mergern Acquisition: 0.00
IPCALAB.NS income_statement (annual, 2025-03-31) — +Operating Expense: 45682300000.00
IPCALAB.NS income_statement (quarterly, 2025-03-31) — +Operating Expense: 12096600000.00
IPCALAB.NS income_statement (annual, 2025-03-31) — +Total Revenue: 88546000000.00
IPCALAB.NS income_statement (quarterly, 2025-03-31) — +Total Revenue: 22466900000.00
IPCALAB.NS balance_sheet (annual, 2025-03-31) — Accounts Payable: 8461700000.00
IPCALAB.NS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 8461700000.00
IPCALAB.NS balance_sheet (annual, 2025-03-31) — Accounts Receivable: 18841400000.00
IPCALAB.NS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 18841400000.00
IPCALAB.NS balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -25747400000.00
IPCALAB.NS balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -25747400000.00
IPCALAB.NS balance_sheet (annual, 2025-03-31) — Additional Paid In Capital: 967800000.00
IPCALAB.NS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 967800000.00
IPCALAB.NS balance_sheet (annual, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -64400000.00
IPCALAB.NS balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -64400000.00
IPCALAB.NS income_statement (annual, 2025-03-31) — Amortization: 199700000.00
IPCALAB.NS cash_flow (annual, 2025-03-31) — Amortization Cash Flow: 199700000.00
IPCALAB.NS balance_sheet (annual, 2025-03-31) — Assets Held For Sale Current: 3015000000.00
IPCALAB.NS balance_sheet (quarterly, 2025-03-31) — Assets Held For Sale Current: 3015000000.00
IPCALAB.NS balance_sheet (annual, 2025-03-31) — Available For Sale Securities: 409900000.00
IPCALAB.NS balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 409900000.00
IPCALAB.NS income_statement (annual, 2025-03-31) — Basic Average Shares: 253704218.00
IPCALAB.NS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 254007491.00
IPCALAB.NS income_statement (annual, 2025-03-31) — Basic EPS: 29.08
IPCALAB.NS income_statement (quarterly, 2025-03-31) — Basic EPS: 2.67
IPCALAB.NS cash_flow (annual, 2025-03-31) — Beginning Cash Position: 7557900000.00
IPCALAB.NS balance_sheet (annual, 2025-03-31) — Buildings And Improvements: 14444700000.00
IPCALAB.NS balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 14444700000.00
IPCALAB.NS cash_flow (annual, 2025-03-31) — Capital Expenditure: -7755700000.00
IPCALAB.NS cash_flow (annual, 2025-03-31) — Capital Expenditure Reported: -500000.00
IPCALAB.NS balance_sheet (annual, 2025-03-31) — Capital Lease Obligations: 610400000.00
IPCALAB.NS balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 610400000.00
IPCALAB.NS balance_sheet (annual, 2025-03-31) — Capital Stock: 253700000.00
IPCALAB.NS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 253700000.00
IPCALAB.NS balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 1671700000.00
IPCALAB.NS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 1671700000.00
IPCALAB.NS balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 11050500000.00
IPCALAB.NS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 11050500000.00
IPCALAB.NS cash_flow (annual, 2025-03-31) — Cash Dividends Paid: -1014800000.00
IPCALAB.NS balance_sheet (annual, 2025-03-31) — Cash Equivalents: 388300000.00
IPCALAB.NS balance_sheet (quarterly, 2025-03-31) — Cash Equivalents: 388300000.00
IPCALAB.NS balance_sheet (annual, 2025-03-31) — Cash Financial: 1283400000.00
IPCALAB.NS balance_sheet (quarterly, 2025-03-31) — Cash Financial: 1283400000.00
IPCALAB.NS cash_flow (annual, 2025-03-31) — Change In Inventory: -915600000.00
IPCALAB.NS cash_flow (annual, 2025-03-31) — Change In Other Current Assets: 1163900000.00
IPCALAB.NS cash_flow (annual, 2025-03-31) — Change In Other Current Liabilities: -786900000.00
IPCALAB.NS cash_flow (annual, 2025-03-31) — Change In Payable: 726600000.00
IPCALAB.NS cash_flow (annual, 2025-03-31) — Change In Receivables: -2176700000.00
IPCALAB.NS cash_flow (annual, 2025-03-31) — Change In Working Capital: -1764600000.00
IPCALAB.NS cash_flow (annual, 2025-03-31) — Changes In Cash: 1688400000.00
IPCALAB.NS balance_sheet (annual, 2025-03-31) — Common Stock: 253700000.00
IPCALAB.NS balance_sheet (quarterly, 2025-03-31) — Common Stock: 253700000.00
IPCALAB.NS balance_sheet (annual, 2025-03-31) — Common Stock Equity: 69484500000.00
IPCALAB.NS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 69484500000.00
IPCALAB.NS balance_sheet (annual, 2025-03-31) — Construction In Progress: 6937100000.00
IPCALAB.NS balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 6937100000.00
IPCALAB.NS income_statement (annual, 2025-03-31) — Cost Of Revenue: 29305000000.00
IPCALAB.NS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 7082900000.00
IPCALAB.NS balance_sheet (annual, 2025-03-31) — Current Assets: 62685400000.00
IPCALAB.NS balance_sheet (quarterly, 2025-03-31) — Current Assets: 62685400000.00
IPCALAB.NS balance_sheet (annual, 2025-03-31) — Current Capital Lease Obligation: 101400000.00
IPCALAB.NS balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 101400000.00
IPCALAB.NS balance_sheet (annual, 2025-03-31) — Current Debt: 7584600000.00
IPCALAB.NS balance_sheet (quarterly, 2025-03-31) — Current Debt: 7584600000.00
IPCALAB.NS balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 7686000000.00
IPCALAB.NS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 7686000000.00
IPCALAB.NS balance_sheet (annual, 2025-03-31) — Current Deferred Taxes Liabilities: 482500000.00
IPCALAB.NS balance_sheet (quarterly, 2025-03-31) — Current Deferred Taxes Liabilities: 482500000.00
IPCALAB.NS balance_sheet (annual, 2025-03-31) — Current Liabilities: 23862200000.00
IPCALAB.NS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 23862200000.00
IPCALAB.NS balance_sheet (annual, 2025-03-31) — Current Provisions: 2691700000.00
IPCALAB.NS balance_sheet (quarterly, 2025-03-31) — Current Provisions: 2691700000.00
IPCALAB.NS cash_flow (annual, 2025-03-31) — Depreciation: 3778500000.00
IPCALAB.NS cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 3978200000.00
IPCALAB.NS income_statement (annual, 2025-03-31) — Depreciation And Amortization In Income Statement: 3978200000.00
IPCALAB.NS income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 1001200000.00
IPCALAB.NS income_statement (annual, 2025-03-31) — Depreciation Income Statement: 3778500000.00
IPCALAB.NS income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 1001200000.00
IPCALAB.NS income_statement (annual, 2025-03-31) — Diluted Average Shares: 253704218.00
IPCALAB.NS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 254007491.00
IPCALAB.NS income_statement (annual, 2025-03-31) — Diluted EPS: 29.08
IPCALAB.NS income_statement (quarterly, 2025-03-31) — Diluted EPS: 2.67
IPCALAB.NS income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: 7376800000.00
IPCALAB.NS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 678200000.00
IPCALAB.NS balance_sheet (annual, 2025-03-31) — Dividends Payable: 25800000.00
IPCALAB.NS balance_sheet (quarterly, 2025-03-31) — Dividends Payable: 25800000.00
IPCALAB.NS income_statement (annual, 2025-03-31) — EBIT: 12154600000.00
IPCALAB.NS income_statement (quarterly, 2025-03-31) — EBIT: 1495100000.00
IPCALAB.NS income_statement (annual, 2025-03-31) — EBITDA: 16132800000.00
IPCALAB.NS income_statement (quarterly, 2025-03-31) — EBITDA: 2496300000.00
IPCALAB.NS cash_flow (annual, 2025-03-31) — End Cash Position: 9246300000.00
IPCALAB.NS balance_sheet (annual, 2025-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 600000.00
IPCALAB.NS balance_sheet (quarterly, 2025-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 600000.00
IPCALAB.NS cash_flow (annual, 2025-03-31) — Financing Cash Flow: -2829800000.00
IPCALAB.NS balance_sheet (annual, 2025-03-31) — Finished Goods: 10755900000.00
IPCALAB.NS balance_sheet (quarterly, 2025-03-31) — Finished Goods: 10755900000.00
IPCALAB.NS cash_flow (annual, 2025-03-31) — Free Cash Flow: 5457500000.00
IPCALAB.NS cash_flow (annual, 2025-03-31) — Gain Loss On Investment Securities: 40300000.00
IPCALAB.NS cash_flow (annual, 2025-03-31) — Gain Loss On Sale Of Business: 0.00
IPCALAB.NS cash_flow (annual, 2025-03-31) — Gain Loss On Sale Of PPE: -7400000.00
IPCALAB.NS income_statement (annual, 2025-03-31) — General And Administrative Expense: 1237500000.00
IPCALAB.NS balance_sheet (annual, 2025-03-31) — Goodwill: 905800000.00
IPCALAB.NS balance_sheet (quarterly, 2025-03-31) — Goodwill: 905800000.00
IPCALAB.NS balance_sheet (annual, 2025-03-31) — Goodwill And Other Intangible Assets: 2032400000.00
IPCALAB.NS balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 2032400000.00
IPCALAB.NS balance_sheet (annual, 2025-03-31) — Gross Accounts Receivable: 18905800000.00
IPCALAB.NS balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 18905800000.00
IPCALAB.NS balance_sheet (annual, 2025-03-31) — Gross PPE: 73373600000.00
IPCALAB.NS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 73373600000.00
IPCALAB.NS income_statement (annual, 2025-03-31) — Gross Profit: 59241000000.00
IPCALAB.NS income_statement (quarterly, 2025-03-31) — Gross Profit: 15384000000.00
IPCALAB.NS income_statement (annual, 2025-03-31) — Impairment Of Capital Assets: 269900000.00
IPCALAB.NS income_statement (annual, 2025-03-31) — Interest Expense: 843200000.00
IPCALAB.NS income_statement (quarterly, 2025-03-31) — Interest Expense: 215100000.00
IPCALAB.NS income_statement (annual, 2025-03-31) — Interest Expense Non Operating: 843200000.00
IPCALAB.NS income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 215100000.00
IPCALAB.NS income_statement (annual, 2025-03-31) — Interest Income: 351200000.00
IPCALAB.NS income_statement (annual, 2025-03-31) — Interest Income Non Operating: 351200000.00
IPCALAB.NS cash_flow (annual, 2025-03-31) — Interest Paid Cff: -743500000.00
IPCALAB.NS cash_flow (annual, 2025-03-31) — Interest Received Cfi: 240000000.00
IPCALAB.NS balance_sheet (annual, 2025-03-31) — Inventory: 25604200000.00
IPCALAB.NS balance_sheet (quarterly, 2025-03-31) — Inventory: 25604200000.00
IPCALAB.NS balance_sheet (annual, 2025-03-31) — Invested Capital: 82501500000.00
IPCALAB.NS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 82501500000.00
IPCALAB.NS cash_flow (annual, 2025-03-31) — Investing Cash Flow: -8695000000.00
IPCALAB.NS balance_sheet (annual, 2025-03-31) — Investmentin Financial Assets: 410500000.00
IPCALAB.NS balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 410500000.00
IPCALAB.NS balance_sheet (annual, 2025-03-31) — Investmentsin Associatesat Cost: -237600000.00
IPCALAB.NS balance_sheet (quarterly, 2025-03-31) — Investmentsin Associatesat Cost: -237600000.00
IPCALAB.NS balance_sheet (annual, 2025-03-31) — Investmentsin Joint Venturesat Cost: 2147600000.00
IPCALAB.NS balance_sheet (quarterly, 2025-03-31) — Investmentsin Joint Venturesat Cost: 2147600000.00
IPCALAB.NS cash_flow (annual, 2025-03-31) — Issuance Of Debt: 2183700000.00
IPCALAB.NS balance_sheet (annual, 2025-03-31) — Land And Improvements: 3115500000.00
IPCALAB.NS balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 3115500000.00
IPCALAB.NS balance_sheet (annual, 2025-03-31) — Long Term Capital Lease Obligation: 509000000.00
IPCALAB.NS balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 509000000.00
IPCALAB.NS balance_sheet (annual, 2025-03-31) — Long Term Debt: 5432400000.00
IPCALAB.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 5432400000.00
IPCALAB.NS balance_sheet (annual, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 5941400000.00
IPCALAB.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 5941400000.00
IPCALAB.NS cash_flow (annual, 2025-03-31) — Long Term Debt Issuance: 2183700000.00
IPCALAB.NS cash_flow (annual, 2025-03-31) — Long Term Debt Payments: -2476800000.00
IPCALAB.NS balance_sheet (annual, 2025-03-31) — Long Term Equity Investment: 1910000000.00
IPCALAB.NS balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 1910000000.00
IPCALAB.NS balance_sheet (annual, 2025-03-31) — Long Term Provisions: 963100000.00
IPCALAB.NS balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 963100000.00
IPCALAB.NS balance_sheet (annual, 2025-03-31) — Machinery Furniture Equipment: 46686800000.00
IPCALAB.NS balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 46686800000.00
IPCALAB.NS balance_sheet (annual, 2025-03-31) — Minority Interest: 14398200000.00
IPCALAB.NS balance_sheet (quarterly, 2025-03-31) — Minority Interest: 14398200000.00
IPCALAB.NS income_statement (annual, 2025-03-31) — Minority Interests: -475600000.00
IPCALAB.NS income_statement (quarterly, 2025-03-31) — Minority Interests: 38300000.00
IPCALAB.NS cash_flow (annual, 2025-03-31) — Net Business Purchase And Sale: -272000000.00
IPCALAB.NS balance_sheet (annual, 2025-03-31) — Net Debt: 11345300000.00
IPCALAB.NS balance_sheet (quarterly, 2025-03-31) — Net Debt: 11345300000.00
IPCALAB.NS cash_flow (annual, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: 101600000.00
IPCALAB.NS income_statement (annual, 2025-03-31) — Net Income: 7376800000.00
IPCALAB.NS income_statement (quarterly, 2025-03-31) — Net Income: 678200000.00
IPCALAB.NS income_statement (annual, 2025-03-31) — Net Income Common Stockholders: 7376800000.00
IPCALAB.NS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 678200000.00
IPCALAB.NS income_statement (annual, 2025-03-31) — Net Income Continuous Operations: 7852400000.00
IPCALAB.NS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 639900000.00
IPCALAB.NS income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 7376800000.00
IPCALAB.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 678200000.00
IPCALAB.NS income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 7376800000.00
IPCALAB.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 678200000.00
IPCALAB.NS cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: 11311400000.00
IPCALAB.NS income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: 7852400000.00
IPCALAB.NS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 639900000.00
IPCALAB.NS income_statement (annual, 2025-03-31) — Net Interest Income: -527200000.00
IPCALAB.NS income_statement (quarterly, 2025-03-31) — Net Interest Income: -215100000.00
IPCALAB.NS cash_flow (annual, 2025-03-31) — Net Investment Purchase And Sale: -1033900000.00
IPCALAB.NS cash_flow (annual, 2025-03-31) — Net Issuance Payments Of Debt: -932500000.00
IPCALAB.NS cash_flow (annual, 2025-03-31) — Net Long Term Debt Issuance: -293100000.00
IPCALAB.NS income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: -527200000.00
IPCALAB.NS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -215100000.00
IPCALAB.NS cash_flow (annual, 2025-03-31) — Net Other Investing Changes: -971400000.00
IPCALAB.NS balance_sheet (annual, 2025-03-31) — Net PPE: 47626200000.00
IPCALAB.NS balance_sheet (quarterly, 2025-03-31) — Net PPE: 47626200000.00
IPCALAB.NS cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: -7701900000.00
IPCALAB.NS cash_flow (annual, 2025-03-31) — Net Short Term Debt Issuance: -639400000.00
IPCALAB.NS balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 67452100000.00
IPCALAB.NS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 67452100000.00
IPCALAB.NS balance_sheet (annual, 2025-03-31) — Non Current Accrued Expenses: 0.00
IPCALAB.NS balance_sheet (quarterly, 2025-03-31) — Non Current Accrued Expenses: 0.00
IPCALAB.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Revenue: 0.00
IPCALAB.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Revenue: 0.00
IPCALAB.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Assets: 169200000.00
IPCALAB.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 169200000.00
IPCALAB.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Liabilities: 2949700000.00
IPCALAB.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 2949700000.00
IPCALAB.NS balance_sheet (annual, 2025-03-31) — Non Current Prepaid Assets: 945800000.00
IPCALAB.NS balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 945800000.00
IPCALAB.NS income_statement (annual, 2025-03-31) — Normalized EBITDA: 18266000000.00
IPCALAB.NS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 4546800000.00
IPCALAB.NS income_statement (annual, 2025-03-31) — Normalized Income: 8861991042.66
IPCALAB.NS income_statement (quarterly, 2025-03-31) — Normalized Income: 2113550000.00
IPCALAB.NS cash_flow (annual, 2025-03-31) — Operating Cash Flow: 13213200000.00
IPCALAB.NS income_statement (annual, 2025-03-31) — Operating Income: 13558700000.00
IPCALAB.NS income_statement (quarterly, 2025-03-31) — Operating Income: 3287400000.00
IPCALAB.NS income_statement (annual, 2025-03-31) — Operating Revenue: 88546000000.00
IPCALAB.NS income_statement (quarterly, 2025-03-31) — Operating Revenue: 22466900000.00
IPCALAB.NS balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 253704218.00
IPCALAB.NS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 253704218.00
IPCALAB.NS balance_sheet (annual, 2025-03-31) — Other Current Assets: 79600000.00
IPCALAB.NS balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 79600000.00
IPCALAB.NS balance_sheet (annual, 2025-03-31) — Other Current Liabilities: 867800000.00
IPCALAB.NS balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 867800000.00
IPCALAB.NS balance_sheet (annual, 2025-03-31) — Other Equity Interest: -244300000.00
IPCALAB.NS balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: -244300000.00
IPCALAB.NS balance_sheet (annual, 2025-03-31) — Other Intangible Assets: 1126600000.00
IPCALAB.NS balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 1126600000.00
IPCALAB.NS balance_sheet (annual, 2025-03-31) — Other Inventories: 896300000.00
IPCALAB.NS balance_sheet (quarterly, 2025-03-31) — Other Inventories: 896300000.00
IPCALAB.NS cash_flow (annual, 2025-03-31) — Other Non Cash Items: 514900000.00
IPCALAB.NS balance_sheet (annual, 2025-03-31) — Other Non Current Assets: 248700000.00
IPCALAB.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 248700000.00
IPCALAB.NS balance_sheet (annual, 2025-03-31) — Other Non Current Liabilities: 6400000.00
IPCALAB.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 6400000.00
IPCALAB.NS income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: 83000000.00
IPCALAB.NS income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 258200000.00
IPCALAB.NS income_statement (annual, 2025-03-31) — Other Operating Expenses: 10500600000.00
IPCALAB.NS income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 6087000000.00
IPCALAB.NS balance_sheet (annual, 2025-03-31) — Other Payable: 3535900000.00
IPCALAB.NS balance_sheet (quarterly, 2025-03-31) — Other Payable: 3535900000.00
IPCALAB.NS balance_sheet (annual, 2025-03-31) — Other Properties: 2189500000.00
IPCALAB.NS balance_sheet (quarterly, 2025-03-31) — Other Properties: 2189500000.00
IPCALAB.NS balance_sheet (annual, 2025-03-31) — Other Receivables: 971300000.00
IPCALAB.NS balance_sheet (quarterly, 2025-03-31) — Other Receivables: 971300000.00
IPCALAB.NS balance_sheet (annual, 2025-03-31) — Other Short Term Investments: 9378800000.00
IPCALAB.NS balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 9378800000.00
IPCALAB.NS income_statement (annual, 2025-03-31) — Other Special Charges: -7400000.00
IPCALAB.NS income_statement (annual, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
IPCALAB.NS income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
IPCALAB.NS balance_sheet (annual, 2025-03-31) — Payables: 12626700000.00
IPCALAB.NS balance_sheet (quarterly, 2025-03-31) — Payables: 12626700000.00
IPCALAB.NS balance_sheet (annual, 2025-03-31) — Prepaid Assets: 1052400000.00
IPCALAB.NS balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 1052400000.00
IPCALAB.NS income_statement (annual, 2025-03-31) — Pretax Income: 11311400000.00
IPCALAB.NS income_statement (quarterly, 2025-03-31) — Pretax Income: 1280000000.00
IPCALAB.NS balance_sheet (annual, 2025-03-31) — Properties: 0.00
IPCALAB.NS balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
IPCALAB.NS cash_flow (annual, 2025-03-31) — Provisionand Write Offof Assets: 1215700000.00
IPCALAB.NS cash_flow (annual, 2025-03-31) — Purchase Of Business: -272000000.00
IPCALAB.NS cash_flow (annual, 2025-03-31) — Purchase Of Investment: -1033900000.00
IPCALAB.NS cash_flow (annual, 2025-03-31) — Purchase Of PPE: -7755200000.00
IPCALAB.NS balance_sheet (annual, 2025-03-31) — Raw Materials: 9951400000.00
IPCALAB.NS balance_sheet (quarterly, 2025-03-31) — Raw Materials: 9951400000.00
IPCALAB.NS income_statement (annual, 2025-03-31) — Reconciled Cost Of Revenue: 29305000000.00
IPCALAB.NS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 7082900000.00
IPCALAB.NS income_statement (annual, 2025-03-31) — Reconciled Depreciation: 3978200000.00
IPCALAB.NS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 1001200000.00
IPCALAB.NS income_statement (annual, 2025-03-31) — Rent And Landing Fees: 177500000.00
IPCALAB.NS income_statement (annual, 2025-03-31) — Rent Expense Supplemental: 177500000.00
IPCALAB.NS cash_flow (annual, 2025-03-31) — Repayment Of Debt: -2476800000.00
IPCALAB.NS income_statement (annual, 2025-03-31) — Research And Development: 805400000.00
IPCALAB.NS balance_sheet (annual, 2025-03-31) — Restricted Cash: 25700000.00
IPCALAB.NS balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 25700000.00
IPCALAB.NS income_statement (annual, 2025-03-31) — Restructuring And Mergern Acquisition: 0.00
IPCALAB.NS income_statement (quarterly, 2025-03-31) — Restructuring And Mergern Acquisition: 0.00
IPCALAB.NS balance_sheet (annual, 2025-03-31) — Retained Earnings: 55313300000.00
IPCALAB.NS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 55313300000.00
IPCALAB.NS cash_flow (annual, 2025-03-31) — Sale Of Investment: 0.00
IPCALAB.NS cash_flow (annual, 2025-03-31) — Sale Of PPE: 53300000.00
IPCALAB.NS income_statement (annual, 2025-03-31) — Selling And Marketing Expense: 8756400000.00
IPCALAB.NS income_statement (annual, 2025-03-31) — Selling General And Administration: 9993900000.00
IPCALAB.NS balance_sheet (annual, 2025-03-31) — Share Issued: 253704218.00
IPCALAB.NS balance_sheet (quarterly, 2025-03-31) — Share Issued: 253704218.00
IPCALAB.NS income_statement (annual, 2025-03-31) — Special Income Charges: -2599400000.00
IPCALAB.NS income_statement (quarterly, 2025-03-31) — Special Income Charges: -2050500000.00
IPCALAB.NS cash_flow (annual, 2025-03-31) — Stock Based Compensation: 20600000.00
IPCALAB.NS balance_sheet (annual, 2025-03-31) — Stockholders Equity: 69484500000.00
IPCALAB.NS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 69484500000.00
IPCALAB.NS balance_sheet (annual, 2025-03-31) — Tangible Book Value: 67452100000.00
IPCALAB.NS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 67452100000.00
IPCALAB.NS income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: -648008957.34
IPCALAB.NS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: -615150000.00
IPCALAB.NS income_statement (annual, 2025-03-31) — Tax Provision: 3436100000.00
IPCALAB.NS income_statement (quarterly, 2025-03-31) — Tax Provision: 622200000.00
IPCALAB.NS income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.30
IPCALAB.NS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.30
IPCALAB.NS balance_sheet (annual, 2025-03-31) — Taxes Receivable: 2045300000.00
IPCALAB.NS balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 2045300000.00
IPCALAB.NS cash_flow (annual, 2025-03-31) — Taxes Refund Paid: -3612500000.00
IPCALAB.NS balance_sheet (annual, 2025-03-31) — Total Assets: 117605500000.00
IPCALAB.NS balance_sheet (quarterly, 2025-03-31) — Total Assets: 117605500000.00
IPCALAB.NS balance_sheet (annual, 2025-03-31) — Total Capitalization: 74916900000.00
IPCALAB.NS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 74916900000.00
IPCALAB.NS balance_sheet (annual, 2025-03-31) — Total Debt: 13627400000.00
IPCALAB.NS balance_sheet (quarterly, 2025-03-31) — Total Debt: 13627400000.00
IPCALAB.NS balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 83882700000.00
IPCALAB.NS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 83882700000.00
IPCALAB.NS income_statement (annual, 2025-03-31) — Total Expenses: 74987300000.00
IPCALAB.NS income_statement (quarterly, 2025-03-31) — Total Expenses: 19179500000.00
IPCALAB.NS balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 33722800000.00
IPCALAB.NS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 33722800000.00
IPCALAB.NS balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 54920100000.00
IPCALAB.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 54920100000.00
IPCALAB.NS balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 9860600000.00
IPCALAB.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 9860600000.00
IPCALAB.NS income_statement (annual, 2025-03-31) — Total Other Finance Cost: 35200000.00
IPCALAB.NS balance_sheet (annual, 2025-03-31) — Total Tax Payable: 603300000.00
IPCALAB.NS balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 603300000.00
IPCALAB.NS income_statement (annual, 2025-03-31) — Total Unusual Items: -2133200000.00
IPCALAB.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items: -2050500000.00
IPCALAB.NS income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: -2133200000.00
IPCALAB.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -2050500000.00
IPCALAB.NS balance_sheet (annual, 2025-03-31) — Tradeand Other Payables Non Current: 6400000.00
IPCALAB.NS balance_sheet (quarterly, 2025-03-31) — Tradeand Other Payables Non Current: 6400000.00
IPCALAB.NS balance_sheet (annual, 2025-03-31) — Work In Process: 4000600000.00
IPCALAB.NS balance_sheet (quarterly, 2025-03-31) — Work In Process: 4000600000.00
IPCALAB.NS balance_sheet (annual, 2025-03-31) — Working Capital: 38823200000.00
IPCALAB.NS balance_sheet (quarterly, 2025-03-31) — Working Capital: 38823200000.00
IPCALAB.NS income_statement (annual, 2025-03-31) — Write Off: 2336900000.00
IPCALAB.NS income_statement (quarterly, 2025-03-31) — Write Off: 2050500000.00
IPCALAB.NS income_statement (quarterly, 2025-06-30) — +Operating Expense: 13009300000.00
IPCALAB.NS income_statement (quarterly, 2025-06-30) — +Total Revenue: 23088500000.00
IPCALAB.NS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 253764962.00
IPCALAB.NS income_statement (quarterly, 2025-06-30) — Basic EPS: 9.19
IPCALAB.NS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 6915600000.00
IPCALAB.NS income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 1000600000.00
IPCALAB.NS income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 1000600000.00
IPCALAB.NS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 253764962.00
IPCALAB.NS income_statement (quarterly, 2025-06-30) — Diluted EPS: 9.19
IPCALAB.NS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 2332100000.00
IPCALAB.NS income_statement (quarterly, 2025-06-30) — EBIT: 3490200000.00
IPCALAB.NS income_statement (quarterly, 2025-06-30) — EBITDA: 4490800000.00
IPCALAB.NS income_statement (quarterly, 2025-06-30) — Gross Profit: 16172900000.00
IPCALAB.NS income_statement (quarterly, 2025-06-30) — Impairment Of Capital Assets: 0.00
IPCALAB.NS income_statement (quarterly, 2025-06-30) — Interest Expense: 185100000.00
IPCALAB.NS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 185100000.00
IPCALAB.NS income_statement (quarterly, 2025-06-30) — Minority Interests: 3200000.00
IPCALAB.NS income_statement (quarterly, 2025-06-30) — Net Income: 2332100000.00
IPCALAB.NS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 2332100000.00
IPCALAB.NS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 2328900000.00
IPCALAB.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 2332100000.00
IPCALAB.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 2332100000.00
IPCALAB.NS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 2328900000.00
IPCALAB.NS income_statement (quarterly, 2025-06-30) — Net Interest Income: -185100000.00
IPCALAB.NS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -185100000.00
IPCALAB.NS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 4490800000.00
IPCALAB.NS income_statement (quarterly, 2025-06-30) — Normalized Income: 2332100000.00
IPCALAB.NS income_statement (quarterly, 2025-06-30) — Operating Income: 3163600000.00
IPCALAB.NS income_statement (quarterly, 2025-06-30) — Operating Revenue: 23088500000.00
IPCALAB.NS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 326600000.00
IPCALAB.NS income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 6577000000.00
IPCALAB.NS income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
IPCALAB.NS income_statement (quarterly, 2025-06-30) — Pretax Income: 3305100000.00
IPCALAB.NS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 6915600000.00
IPCALAB.NS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 1000600000.00
IPCALAB.NS income_statement (quarterly, 2025-06-30) — Special Income Charges: 0.00
IPCALAB.NS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
IPCALAB.NS income_statement (quarterly, 2025-06-30) — Tax Provision: 960900000.00
IPCALAB.NS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.29
IPCALAB.NS income_statement (quarterly, 2025-06-30) — Total Expenses: 19924900000.00
IPCALAB.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items: 0.00
IPCALAB.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 0.00
IPCALAB.NS income_statement (quarterly, 2025-06-30) — Write Off: 0.00
IPCALAB.NS income_statement (quarterly, 2025-09-30) — +Operating Expense: 13332700000.00
IPCALAB.NS income_statement (quarterly, 2025-09-30) — +Total Revenue: 25565000000.00
IPCALAB.NS balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 8216000000.00
IPCALAB.NS balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 20770600000.00
IPCALAB.NS balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 1364400000.00
IPCALAB.NS income_statement (quarterly, 2025-09-30) — Basic Average Shares: 253653501.00
IPCALAB.NS income_statement (quarterly, 2025-09-30) — Basic EPS: 11.14
IPCALAB.NS balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 737400000.00
IPCALAB.NS balance_sheet (quarterly, 2025-09-30) — Capital Stock: 253700000.00
IPCALAB.NS balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 2129500000.00
IPCALAB.NS balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 12829000000.00
IPCALAB.NS balance_sheet (quarterly, 2025-09-30) — Common Stock: 253700000.00
IPCALAB.NS balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 74269000000.00
IPCALAB.NS balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 7768700000.00
IPCALAB.NS income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 7816400000.00
IPCALAB.NS balance_sheet (quarterly, 2025-09-30) — Current Assets: 62518600000.00
IPCALAB.NS balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 117100000.00
IPCALAB.NS balance_sheet (quarterly, 2025-09-30) — Current Debt: 8049900000.00
IPCALAB.NS balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 8167000000.00
IPCALAB.NS balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 25374600000.00
IPCALAB.NS balance_sheet (quarterly, 2025-09-30) — Current Provisions: 3295600000.00
IPCALAB.NS income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 1033300000.00
IPCALAB.NS income_statement (quarterly, 2025-09-30) — Depreciation Income Statement: 1033300000.00
IPCALAB.NS income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 253653501.00
IPCALAB.NS income_statement (quarterly, 2025-09-30) — Diluted EPS: 11.14
IPCALAB.NS income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 2825700000.00
IPCALAB.NS income_statement (quarterly, 2025-09-30) — EBIT: 4111900000.00
IPCALAB.NS income_statement (quarterly, 2025-09-30) — EBITDA: 5145200000.00
IPCALAB.NS balance_sheet (quarterly, 2025-09-30) — Goodwill: 828100000.00
IPCALAB.NS balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 2028400000.00
IPCALAB.NS balance_sheet (quarterly, 2025-09-30) — Gross PPE: 49447600000.00
IPCALAB.NS income_statement (quarterly, 2025-09-30) — Gross Profit: 17748600000.00
IPCALAB.NS income_statement (quarterly, 2025-09-30) — Interest Expense: 196100000.00
IPCALAB.NS income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 196100000.00
IPCALAB.NS balance_sheet (quarterly, 2025-09-30) — Inventory: 25158700000.00
IPCALAB.NS balance_sheet (quarterly, 2025-09-30) — Invested Capital: 86320800000.00
IPCALAB.NS balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 1364400000.00
IPCALAB.NS balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 620300000.00
IPCALAB.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 4001900000.00
IPCALAB.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 4622200000.00
IPCALAB.NS balance_sheet (quarterly, 2025-09-30) — Long Term Equity Investment: 1865000000.00
IPCALAB.NS balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 1009900000.00
IPCALAB.NS balance_sheet (quarterly, 2025-09-30) — Minority Interest: 14389200000.00
IPCALAB.NS income_statement (quarterly, 2025-09-30) — Minority Interests: 20400000.00
IPCALAB.NS balance_sheet (quarterly, 2025-09-30) — Net Debt: 9922300000.00
IPCALAB.NS income_statement (quarterly, 2025-09-30) — Net Income: 2825700000.00
IPCALAB.NS income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 2825700000.00
IPCALAB.NS income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 2805300000.00
IPCALAB.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 2825700000.00
IPCALAB.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 2825700000.00
IPCALAB.NS income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 2805300000.00
IPCALAB.NS income_statement (quarterly, 2025-09-30) — Net Interest Income: -196100000.00
IPCALAB.NS income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -196100000.00
IPCALAB.NS balance_sheet (quarterly, 2025-09-30) — Net PPE: 49447600000.00
IPCALAB.NS balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 72240600000.00
IPCALAB.NS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 181500000.00
IPCALAB.NS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 2957500000.00
IPCALAB.NS income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 5727800000.00
IPCALAB.NS income_statement (quarterly, 2025-09-30) — Normalized Income: 3247496567.75
IPCALAB.NS income_statement (quarterly, 2025-09-30) — Operating Income: 4415900000.00
IPCALAB.NS income_statement (quarterly, 2025-09-30) — Operating Revenue: 25565000000.00
IPCALAB.NS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 253704218.00
IPCALAB.NS balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 3246900000.00
IPCALAB.NS balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 968300000.00
IPCALAB.NS balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 74015300000.00
IPCALAB.NS balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 1200300000.00
IPCALAB.NS balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 2377200000.00
IPCALAB.NS balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 4200000.00
IPCALAB.NS income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 278600000.00
IPCALAB.NS income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 6920000000.00
IPCALAB.NS balance_sheet (quarterly, 2025-09-30) — Other Properties: 41678900000.00
IPCALAB.NS balance_sheet (quarterly, 2025-09-30) — Other Receivables: 513400000.00
IPCALAB.NS balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 10699500000.00
IPCALAB.NS income_statement (quarterly, 2025-09-30) — Other Special Charges: 582600000.00
IPCALAB.NS income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 0.00
IPCALAB.NS balance_sheet (quarterly, 2025-09-30) — Payables: 8739800000.00
IPCALAB.NS income_statement (quarterly, 2025-09-30) — Pretax Income: 3915800000.00
IPCALAB.NS income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 7816400000.00
IPCALAB.NS income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 1033300000.00
IPCALAB.NS balance_sheet (quarterly, 2025-09-30) — Share Issued: 253704218.00
IPCALAB.NS income_statement (quarterly, 2025-09-30) — Special Income Charges: -582600000.00
IPCALAB.NS balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 74269000000.00
IPCALAB.NS balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 72240600000.00
IPCALAB.NS income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: -160803432.25
IPCALAB.NS income_statement (quarterly, 2025-09-30) — Tax Provision: 1080800000.00
IPCALAB.NS income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.28
IPCALAB.NS balance_sheet (quarterly, 2025-09-30) — Taxes Receivable: 0.00
IPCALAB.NS balance_sheet (quarterly, 2025-09-30) — Total Assets: 122626600000.00
IPCALAB.NS balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 78270900000.00
IPCALAB.NS balance_sheet (quarterly, 2025-09-30) — Total Debt: 12789200000.00
IPCALAB.NS balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 88658200000.00
IPCALAB.NS income_statement (quarterly, 2025-09-30) — Total Expenses: 21149100000.00
IPCALAB.NS balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 33968400000.00
IPCALAB.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 60108000000.00
IPCALAB.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 8593800000.00
IPCALAB.NS balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 523800000.00
IPCALAB.NS income_statement (quarterly, 2025-09-30) — Total Unusual Items: -582600000.00
IPCALAB.NS income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -582600000.00
IPCALAB.NS balance_sheet (quarterly, 2025-09-30) — Working Capital: 37144000000.00
IPCALAB.NS income_statement (quarterly, 2025-09-30) — Write Off: 0.00
IPCALAB.NS income_statement (quarterly, 2025-12-31) — +Operating Expense: 13088400000.00
IPCALAB.NS income_statement (quarterly, 2025-12-31) — +Total Revenue: 23925000000.00
IPCALAB.NS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 253709176.00
IPCALAB.NS income_statement (quarterly, 2025-12-31) — Basic EPS: 12.86
IPCALAB.NS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 6579000000.00
IPCALAB.NS income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 1075900000.00
IPCALAB.NS income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 1075900000.00
IPCALAB.NS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 253709176.00
IPCALAB.NS income_statement (quarterly, 2025-12-31) — Diluted EPS: 12.86